HUP0203164A2 - Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékei - Google Patents
Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékeiInfo
- Publication number
- HUP0203164A2 HUP0203164A2 HU0203164A HUP0203164A HUP0203164A2 HU P0203164 A2 HUP0203164 A2 HU P0203164A2 HU 0203164 A HU0203164 A HU 0203164A HU P0203164 A HUP0203164 A HU P0203164A HU P0203164 A2 HUP0203164 A2 HU P0203164A2
- Authority
- HU
- Hungary
- Prior art keywords
- subject
- nucleic acids
- genes involved
- diseases related
- expression products
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
- 230000004060 metabolic process Effects 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9906587A FR2794131B1 (fr) | 1999-05-25 | 1999-05-25 | Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol |
| US13945099P | 1999-06-16 | 1999-06-16 | |
| PCT/FR2000/001426 WO2000071710A2 (fr) | 1999-05-25 | 2000-05-25 | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0203164A2 true HUP0203164A2 (hu) | 2002-12-28 |
Family
ID=26234967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0203164A HUP0203164A2 (hu) | 1999-05-25 | 2000-05-25 | Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékei |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1183350A2 (fr) |
| JP (1) | JP2003518918A (fr) |
| KR (1) | KR20020033627A (fr) |
| AU (1) | AU4931800A (fr) |
| BR (1) | BR0010916A (fr) |
| CA (1) | CA2371500A1 (fr) |
| HU (1) | HUP0203164A2 (fr) |
| IL (1) | IL145835A0 (fr) |
| MX (1) | MXPA01011882A (fr) |
| NO (1) | NO20015729L (fr) |
| WO (1) | WO2000071710A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2367955C (fr) | 1999-03-15 | 2009-05-19 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
| CA2417900A1 (fr) | 2000-08-01 | 2002-02-07 | Amgen Inc. | Molecules du type recepteur de complement c3b/c4b et utilisations de ces molecules |
| AT413701B (de) * | 2001-11-06 | 2006-05-15 | Bmt Medizinische Forschung Und | Strukturelle und funktionelle charakterisierung von cdw92 |
| EP2123676A4 (fr) * | 2007-01-05 | 2011-01-05 | Univ Tokyo | Diagnostic et traitement de cancers utilisant un anticorps anti-prg-3 |
| AU2008321840B2 (en) | 2007-11-14 | 2014-02-06 | Chugai Seiyaku Kabushiki Kaisha | Diagnosis and treatment of cancer using anti-GPR49 antibody |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998020165A2 (fr) * | 1996-11-06 | 1998-05-14 | Whitehead Institute For Biomedical Research | Marqueurs bialleliques |
-
2000
- 2000-05-25 AU AU49318/00A patent/AU4931800A/en not_active Abandoned
- 2000-05-25 HU HU0203164A patent/HUP0203164A2/hu unknown
- 2000-05-25 EP EP00931354A patent/EP1183350A2/fr not_active Withdrawn
- 2000-05-25 BR BR0010916-9A patent/BR0010916A/pt not_active IP Right Cessation
- 2000-05-25 CA CA002371500A patent/CA2371500A1/fr not_active Abandoned
- 2000-05-25 JP JP2000620087A patent/JP2003518918A/ja not_active Withdrawn
- 2000-05-25 KR KR1020017015017A patent/KR20020033627A/ko not_active Application Discontinuation
- 2000-05-25 IL IL14583500A patent/IL145835A0/xx unknown
- 2000-05-25 MX MXPA01011882A patent/MXPA01011882A/es unknown
- 2000-05-25 WO PCT/FR2000/001426 patent/WO2000071710A2/fr not_active Application Discontinuation
-
2001
- 2001-11-23 NO NO20015729A patent/NO20015729L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003518918A (ja) | 2003-06-17 |
| EP1183350A2 (fr) | 2002-03-06 |
| KR20020033627A (ko) | 2002-05-07 |
| WO2000071710A3 (fr) | 2001-05-17 |
| WO2000071710A2 (fr) | 2000-11-30 |
| MXPA01011882A (es) | 2002-05-06 |
| AU4931800A (en) | 2000-12-12 |
| BR0010916A (pt) | 2002-02-19 |
| NO20015729D0 (no) | 2001-11-23 |
| IL145835A0 (en) | 2002-07-25 |
| NO20015729L (no) | 2002-01-22 |
| CA2371500A1 (fr) | 2000-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| Ouhammouch et al. | Activation of archaeal transcription by recruitment of the TATA-binding protein | |
| Xing et al. | Natural polymorphisms are present in the furin cleavage site of the SARS-CoV-2 spike glycoprotein | |
| WO2001070174A8 (fr) | Genes modules par vegf et leurs procedes d'utilisation | |
| BR0316435A (pt) | Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos | |
| WO2004022716A3 (fr) | Mutants recombines de rhabdovirus et leurs procedes d'utilisation | |
| ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
| WO2004067709A3 (fr) | Identification de genes essentiels d'aspergillus fumigatus et methodes d'utilisation | |
| WO2005079367A3 (fr) | Synthase d'acide gras (fas) schizochytrium et produits et procedes connexes | |
| DE69808743T2 (de) | Netrinrezeptoren | |
| FR2823764B1 (fr) | Nouveaux polynucleotides et polypeptides du gene ifn alpha-17 | |
| WO2002048329A3 (fr) | Caspase 3 derivee d'une membrane, compositions contenant cette caspase et procedes d'utilisation associes | |
| WO2003052076A3 (fr) | Identification de genes essentiels de cryptococcus neoformans et methodes d'utilisation associees | |
| DE69816467D1 (de) | Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung | |
| HUP0203164A2 (hu) | Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékei | |
| HUP0203221A2 (hu) | A lignin bioszintézisében résztvevő enzimeket kódoló gének és alkalmazásuk | |
| WO2003029422A3 (fr) | Gene du syndrome de noonan | |
| NZ516237A (en) | Meth1 and meth2 polynucleotides and polypeptides | |
| WO2003025010A3 (fr) | Molecules de proteine delta-n p73 humaine et leur utilisation | |
| WO2003000896A3 (fr) | Nouveaux polynucleotides et polypeptides du gene ifn$g(a)-5 | |
| WO2002033046A3 (fr) | Genes relatifs au transport de glucose | |
| WO2003031594A3 (fr) | Sequences de nucleotides et d'acides amines associees a des maladies respiratoires et a l'obesite | |
| HUP0203801A2 (hu) | Eljárás rekombináns adenovírusok előállítására és adenovírus-könyvtárak | |
| HUP0204524A2 (hu) | A humán ABC1-gén nukleinsavai és fehérjéi és terápiás és diagnosztikai alkalmazásaik | |
| WO2002064827A3 (fr) | Acides nucleiques du gene humain abca12, vecteurs contenant ces acides nucleiques, et utilisations associees |